In recent years, technological advances in artificial intelligence (AI) and machine learning (ML) have enabled companies of all types to analyze massive amounts of data in ways previously impossible and to transform massive amounts of data into novel, usable insights. Yet these technologies carry significant risks that companies must understand as they negotiate transactions, grow their businesses and incorporate AI/ML technologies into their operations. This webinar will provide guidance on key risks associated with AI/ML technologies, including privacy, intellectual property, data transfer, data quality and algorithmic bias.

WilmerHale’s Ariel Soiffer will discuss the application of these technologies to life sciences companies and key considerations in negotiating transactions involving AI/ML. Paul Lekas, senior vice president with the Software & Information Industry Association (SIIA), will address the state of legislative and other policy efforts around AI/ML and the effects these efforts have on businesses in life sciences and across the information landscape.

*CLE credit is not available for those who watch a recording of the webinar.